GALVANI, Elena
GALVANI, Elena
Dipartimento di Medicina Sperimentale (attivo dal 01/01/1900 al 25/07/2012)
Combined use of anti-ErbB monoclonal antibodies and erlotinib enhances antibody-dependent cellular cytotoxicity of wild-type erlotinib-sensitive NSCLC cell lines
2012-01-01 Cavazzoni, A.; Alfieri, R.; Cretella, D.; Saccani, F.; Ampollini, L.; Galetti, M.; Quaini, F.; Graiani., G.; Madeddu, D.; Mozzoni, P.; Galvani, E.; La Monica, S.; Bonelli, M.; Fumarola, C.; Mutti, A.; Carbognani, P.; Tiseo, M.; Barocelli, E.; Petronini, P. G.; Ardizzoni, A.
Effects of sorafenib on energy metabolism in breast cancer cells: role of AMPK-mTORC1 signaling
2013-01-01 Fumarola, Claudia; Caffarra, Cristina; LA MONICA, Silvia; Galetti, Maricla; Alfieri, Roberta; Cavazzoni, Andrea; Galvani, Elena; D., Generali; Petronini, Pier Giorgio; Bonelli, Mara
Epidermal growth factor receptor tyrosine kinase inhibitors: current status and future perspectives in the development of novel irreversible inhibitors for the treatment of mutant non-small cell lung cancer
2013-01-01 Galvani, Elena; Alfieri, Roberta; E., Giovannetti; Cavazzoni, Andrea; LA MONICA, Silvia; Galetti, Maricla; Fumarola, Claudia; Bonelli, Mara; Mor, Marco; Tiseo, Marcello; G. J., Peters; Petronini, Pier Giorgio; Ardizzoni, Andrea
Gefitinib inhibits invasive phenotype and epithelial-mesenchymal transition in drug-resistant NSCLC cells with MET amplification
2013-01-01 LA MONICA, Silvia; Caffarra, Cristina; Saccani, Francesca; Galvani, Elena; Galetti, Maricla; Fumarola, Claudia; Bonelli, Mara; Cavazzoni, Andrea; D., Cretella; R., Sirangelo; Gatti, Rita; Tiseo, Marcello; Ardizzoni, Andrea; E., Giovannetti; Petronini, Pier Giorgio; Alfieri, Roberta
Irreversible Inhibition of Epidermal Growth Factor Receptor Activity by 3-Aminopropanamides.
2012-01-01 Carmi, Caterina; Galvani, Elena; Vacondio, Federica; Rivara, Silvia; Lodola, Alessio; Russo, Simonetta; Bordi, Fabrizio; Costantino, Gianluca; Cavazzoni, Andrea; Alfieri, Roberta; Ardizzoni, A.; Petronini, P. G.; Mor, Marco; Costantino, Gabriele
Metabolism of the EGFR tyrosin kinase inhibitor gefitinib by cytochrome P450 1A1 enzyme in EGFR-wild type non small cell lung cancer cell lines
2011-01-01 Alfieri, Roberta; Galetti, Maricla; Tramonti, S.; Andreoli, Roberta; Mozzoni, Paola; Cavazzoni, Andrea; Bonelli, Mara; Fumarola, Claudia; La Monica, S.; Galvani, Elena; De Palma, G.; Mutti, Antonio; Mor, Marco; Tiseo, M.; Mari, E.; Ardizzoni, A.; Petronini, Pier Giorgio; LA MONICA, Silvia
Molecular mechanisms underlying the antitumor activity of 3-aminopropanamide irreversible inhibitors of the epidermal growth factor receptor in non-small cell lung cancer
2013-01-01 Galvani, Elena; E., Giovannetti; Saccani, Francesca; Cavazzoni, Andrea; L. G., Leon; H., Dekker; Alfieri, Roberta; Carmi, Caterina; Mor, Marco; Ardizzoni, Andrea; Petronini, Pier Giorgio; G. J., Peters
Overcoming acquired resistance to letrozole by targeting the PI3K/AKT/mTOR pathway in breast cancer cell clones. (Cavazzoni and Bonelli co-first authors)
2012-01-01 Cavazzoni, Andrea; Bonelli, Mara; Fumarola, Claudia; LA MONICA, Silvia; Airoud, K; Bertoni, R; Alfieri, Roberta; Galetti, Maricla; Tramonti, S; Galvani, Elena; Harris, Al; Martin, La; Andreis, D; Bottini, A; Generali, D; Petronini, Pier Giorgio
Synergistic activity of letrozole and sorafenib on MCF7/AROM-1 breast cancer cells
2009-01-01 Bonelli, Mara; Fumarola, Claudia; Alfieri, Roberta; LA MONICA, Silvia; Cavazzoni, Andrea; Airoud, K; Galvani, Elena; Galetti, M; Gatti, Rita; Belletti, Silvana; Bottini, A; Generali, D; Petronini, Pier Giorgio
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Combined use of anti-ErbB monoclonal antibodies and erlotinib enhances antibody-dependent cellular cytotoxicity of wild-type erlotinib-sensitive NSCLC cell lines | 1-gen-2012 | Cavazzoni, A.; Alfieri, R.; Cretella, D.; Saccani, F.; Ampollini, L.; Galetti, M.; Quaini, F.; Graiani., G.; Madeddu, D.; Mozzoni, P.; Galvani, E.; La Monica, S.; Bonelli, M.; Fumarola, C.; Mutti, A.; Carbognani, P.; Tiseo, M.; Barocelli, E.; Petronini, P. G.; Ardizzoni, A. | |
| Effects of sorafenib on energy metabolism in breast cancer cells: role of AMPK-mTORC1 signaling | 1-gen-2013 | Fumarola, Claudia; Caffarra, Cristina; LA MONICA, Silvia; Galetti, Maricla; Alfieri, Roberta; Cavazzoni, Andrea; Galvani, Elena; D., Generali; Petronini, Pier Giorgio; Bonelli, Mara | |
| Epidermal growth factor receptor tyrosine kinase inhibitors: current status and future perspectives in the development of novel irreversible inhibitors for the treatment of mutant non-small cell lung cancer | 1-gen-2013 | Galvani, Elena; Alfieri, Roberta; E., Giovannetti; Cavazzoni, Andrea; LA MONICA, Silvia; Galetti, Maricla; Fumarola, Claudia; Bonelli, Mara; Mor, Marco; Tiseo, Marcello; G. J., Peters; Petronini, Pier Giorgio; Ardizzoni, Andrea | |
| Gefitinib inhibits invasive phenotype and epithelial-mesenchymal transition in drug-resistant NSCLC cells with MET amplification | 1-gen-2013 | LA MONICA, Silvia; Caffarra, Cristina; Saccani, Francesca; Galvani, Elena; Galetti, Maricla; Fumarola, Claudia; Bonelli, Mara; Cavazzoni, Andrea; D., Cretella; R., Sirangelo; Gatti, Rita; Tiseo, Marcello; Ardizzoni, Andrea; E., Giovannetti; Petronini, Pier Giorgio; Alfieri, Roberta | |
| Irreversible Inhibition of Epidermal Growth Factor Receptor Activity by 3-Aminopropanamides. | 1-gen-2012 | Carmi, Caterina; Galvani, Elena; Vacondio, Federica; Rivara, Silvia; Lodola, Alessio; Russo, Simonetta; Bordi, Fabrizio; Costantino, Gianluca; Cavazzoni, Andrea; Alfieri, Roberta; Ardizzoni, A.; Petronini, P. G.; Mor, Marco; Costantino, Gabriele | |
| Metabolism of the EGFR tyrosin kinase inhibitor gefitinib by cytochrome P450 1A1 enzyme in EGFR-wild type non small cell lung cancer cell lines | 1-gen-2011 | Alfieri, Roberta; Galetti, Maricla; Tramonti, S.; Andreoli, Roberta; Mozzoni, Paola; Cavazzoni, Andrea; Bonelli, Mara; Fumarola, Claudia; La Monica, S.; Galvani, Elena; De Palma, G.; Mutti, Antonio; Mor, Marco; Tiseo, M.; Mari, E.; Ardizzoni, A.; Petronini, Pier Giorgio; LA MONICA, Silvia | |
| Molecular mechanisms underlying the antitumor activity of 3-aminopropanamide irreversible inhibitors of the epidermal growth factor receptor in non-small cell lung cancer | 1-gen-2013 | Galvani, Elena; E., Giovannetti; Saccani, Francesca; Cavazzoni, Andrea; L. G., Leon; H., Dekker; Alfieri, Roberta; Carmi, Caterina; Mor, Marco; Ardizzoni, Andrea; Petronini, Pier Giorgio; G. J., Peters | |
| Overcoming acquired resistance to letrozole by targeting the PI3K/AKT/mTOR pathway in breast cancer cell clones. (Cavazzoni and Bonelli co-first authors) | 1-gen-2012 | Cavazzoni, Andrea; Bonelli, Mara; Fumarola, Claudia; LA MONICA, Silvia; Airoud, K; Bertoni, R; Alfieri, Roberta; Galetti, Maricla; Tramonti, S; Galvani, Elena; Harris, Al; Martin, La; Andreis, D; Bottini, A; Generali, D; Petronini, Pier Giorgio | |
| Synergistic activity of letrozole and sorafenib on MCF7/AROM-1 breast cancer cells | 1-gen-2009 | Bonelli, Mara; Fumarola, Claudia; Alfieri, Roberta; LA MONICA, Silvia; Cavazzoni, Andrea; Airoud, K; Galvani, Elena; Galetti, M; Gatti, Rita; Belletti, Silvana; Bottini, A; Generali, D; Petronini, Pier Giorgio |